BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8640904)

  • 21. Effect of oxidation on the structure of human low- and high-density lipoproteins.
    Oliveira CL; Santos PR; Monteiro AM; Figueiredo Neto AM
    Biophys J; 2014 Jun; 106(12):2595-605. PubMed ID: 24940777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Composition of plasmalogens in serum lipoproteins from patients with non-alcoholic steatohepatitis and their susceptibility to oxidation.
    Ikuta A; Sakurai T; Nishimukai M; Takahashi Y; Nagasaka A; Hui SP; Hara H; Chiba H
    Clin Chim Acta; 2019 Jun; 493():1-7. PubMed ID: 30796899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LDL and HDL oxidation and fatty acid composition in vegetarians.
    Nagyová A; Krajcovicová-Kudlácková M; Klvanová J
    Ann Nutr Metab; 2001; 45(4):148-51. PubMed ID: 11463997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.
    Parthasarathy S; Barnett J; Fong LG
    Biochim Biophys Acta; 1990 May; 1044(2):275-83. PubMed ID: 2344447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens.
    Jürgens G; Fell A; Ledinski G; Chen Q; Paltauf F
    Chem Phys Lipids; 1995 Aug; 77(1):25-31. PubMed ID: 7586089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of protection against oxidative modification of LDL by avian HDL.
    Mackness B; Durrington PN; Mackness MI
    Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free radical oxidation of plasmalogen glycerophosphocholine containing esterified docosahexaenoic acid: structure determination by mass spectrometry.
    Zemski Berry KA; Murphy RC
    Antioxid Redox Signal; 2005; 7(1-2):157-69. PubMed ID: 15650405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.
    Mackness MI; Abbott C; Arrol S; Durrington PN
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):829-34. PubMed ID: 8379937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin decreases aldehyde production derived from lipoprotein oxidation.
    Girona J; La Ville AE; Solà R; Plana N; Masana L
    Am J Cardiol; 1999 Mar; 83(6):846-51. PubMed ID: 10190397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences.
    Francis GA
    Biochim Biophys Acta; 2000 Jan; 1483(2):217-35. PubMed ID: 10634938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein.
    Thukkani AK; Albert CJ; Wildsmith KR; Messner MC; Martinson BD; Hsu FF; Ford DA
    J Biol Chem; 2003 Sep; 278(38):36365-72. PubMed ID: 12869568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant association of lipid peroxidation products with high density lipoproteins.
    Hahn M; Subbiah MT
    Biochem Mol Biol Int; 1994 Jul; 33(4):699-704. PubMed ID: 7981657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.
    Mackness MI; Arrol S; Abbott C; Durrington PN
    Atherosclerosis; 1993 Dec; 104(1-2):129-35. PubMed ID: 8141836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 3,4-dihydroxyphenylalanine on Cu(2+)-induced inactivation of HDL-associated paraoxonasel and oxidation of HDL; inactivation of paraoxonasel activity independent of HDL lipid oxidation.
    Nguyen SD; Sok DE
    Free Radic Res; 2004 Sep; 38(9):969-76. PubMed ID: 15621715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in the surface charge of plasma lipoproteins during their auto-oxidation].
    Panasenko OM; Azizova OA; Borin ML; Arnol'd K
    Biull Eksp Biol Med; 1986 Jan; 101(1):24-6. PubMed ID: 3002515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of long-chain aldehydes by gas chromatography coupled to mass spectrometry as a tool for simultaneous measurement of plasmalogens and their aldehydic breakdown products.
    Ingrand SS; Wahl A; Favrelière S; Barbot F; Tallineau C
    Anal Biochem; 2000 Apr; 280(1):65-72. PubMed ID: 10805522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidation of Plasmalogen, Low-Density Lipoprotein and RAW 264.7 Cells by Photoactivatable Atomic Oxygen Precursors.
    Bourdillon MT; Ford BA; Knulty AT; Gray CN; Zhang M; Ford D; McCulla RD
    Photochem Photobiol; 2014; 90(2):386-93. PubMed ID: 27096146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red wine antioxidants bind to human lipoproteins and protect them from metal ion-dependent and -independent oxidation.
    Ivanov V; Carr AC; Frei B
    J Agric Food Chem; 2001 Sep; 49(9):4442-9. PubMed ID: 11559152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
    Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
    J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women.
    Wakatsuki A; Ikenoue N; Sagara Y
    Maturitas; 1998 Jan; 28(3):229-34. PubMed ID: 9571598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.